Canopy Growth (CGC)
(Delayed Data from NSDQ)
$9.05 USD
-0.81 (-8.22%)
Updated May 10, 2024 04:00 PM ET
After-Market: $9.05 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CGC 9.05 -0.81(-8.22%)
Will CGC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CGC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CGC
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
CGC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?
Canopy Growth Corporation (CGC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
Other News for CGC
The 3 Best Cannabis Stocks to Buy in May 2024
Canopy Growth call volume above normal and directionally bullish
Rising High: Exclusive talk with Dazed Cannabis
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
Canopy Growth’s (NASDAQ:CGC) Stock Surges as it Ramps Up U.S. Business